Home PD, McCrimmon RJ, Rosenstock J, Bluher M, et al. Findings for iGlarLixi vs BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics. Diabetes Obes Metab 2022 Oct 30. doi: 10.1111/dom.14907.
PMID: 36309941